Harvard Apparatus Regenerative Tech Inc. (HRGN)

[hondobud]

News and a squeeze?

Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Monday 08/07/2017 07:00 AM ET - PR Newswire via Dow Jones News

- Procedure approved via the FDA's single-use expanded access program and was performed at a major U.S. hospital - HOLLISTON, Mass., Aug. 7, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancer, congenital abnormalities and other life-threatening conditions of the esophagus, bronchus and trachea, today announced the use of Biostage's Cellspan Esophageal Implant product candidate in a patient at a major U.S. hospital via an FDA-approved single-use expanded access application.